Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-10-05
1994-11-15
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514312, 546123, 546156, A61K 31435, A61K 3147, C07D47104, C07D21556
Patent
active
053648617
ABSTRACT:
Optically pure isomers of 7-[3-(1,1-dialkylmethyl-1-amino)-1-pyrrolidinyl]quinolones and naphthyridones as therapeutically active and safe antibacterial agents are described, as well as pharmaceutical compositions thereof, and a method of treating bacterial infections therewith. Also described is a method of manufacture of the quinolones and naphthyridones as well as the starting materials, the optically pure pyrrolidine moieties for attachment at the 7-position.
REFERENCES:
patent: 4665079 (1987-05-01), Culbertson et al.
patent: 4780468 (1988-10-01), Bridges et al.
patent: 5098912 (1992-03-01), Hayakawa et al.
Hagen Susan E.
Suto Mark J.
Ashbrook Charles W.
Daignault Ronald A.
Dentz Bernard
Warner-Lambert & Company
LandOfFree
Optical isomers of 7-[3-(1,1-dialkylmethyl-1-amino-1-pyrrolidiny does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Optical isomers of 7-[3-(1,1-dialkylmethyl-1-amino-1-pyrrolidiny, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optical isomers of 7-[3-(1,1-dialkylmethyl-1-amino-1-pyrrolidiny will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1097955